How does your garden grow? For cancer patients, small gardens could bring big benefits

Dr Ceri Phelps - University of Wales Trinity Saint David, UK
How does your garden grow? For cancer patients, small gardens could bring big benefits ( Dr Ceri Phelps - University of Wales Trinity Saint David, UK )
11 Jan 2016

Breast cancer screening in Morocco

Dr Hafida Charaka - Sidi Mohamed Ben Abdellah University, Fez, Morocco
Breast cancer screening in Morocco ( Dr Hafida Charaka - Sidi Mohamed Ben Abdellah University, Fez, Morocco )
4 Jan 2016

What does the iManageCancer project hope to achieve?

Prof Gordon McVie - ecancer Managing Editor
What does the iManageCancer project hope to achieve? ( Prof Gordon McVie - ecancer Managing Editor )
23 Dec 2015

Prediction of side-effects of anti-cancer drugs

Dr Gerard Milano - Centre Antoine Lacassagne, Nice, France
Prediction of side-effects of anti-cancer drugs ( Dr Gerard Milano - Centre Antoine Lacassagne, Nice, France )
22 Dec 2015

Mouse models for complex aspects in human cancer

Dr Peter Bouwman - Netherlands Cancer Institute (NKI), Amsterdam, Netherlands
Mouse models for complex aspects in human cancer ( Dr Peter Bouwman - Netherlands Cancer Institute (NKI), Amsterdam, Netherlands )
22 Dec 2015

Buparlisib helps overcome endocrine resistance in metastatic breast cancer: BELLE-2 trial results

Dr Mario Campone - René Gauducheau Centre de Recherche en Cancérologie, Nantes, France.
Buparlisib helps overcome endocrine resistance in metastatic breast cancer: BELLE-2 trial results ( Dr Mario Campone - René Gauducheau Centre de Recherche en Cancérologie, Nantes, France. )
17 Dec 2015

Survival outcomes from the CALGB 40603 study in triple-negative breast cancer

Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA
Survival outcomes from the CALGB 40603 study in triple-negative breast cancer ( Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA )
17 Dec 2015

TH3RESA: T-DM1 improves overall survival in previously treated advanced cancer patients

Prof Hans Wildiers - University Hospital of Leuven, Leuven, Belgium
TH3RESA: T-DM1 improves overall survival in previously treated advanced cancer patients ( Prof Hans Wildiers - University Hospital of Leuven, Leuven, Belgium )
17 Dec 2015

Molecular evolution of breast cancer during neoadjuvant chemotherapy

Prof Anne-Lise Børresen-Dale - Oslo University Hospital, Oslo, Norway
Molecular evolution of breast cancer during neoadjuvant chemotherapy ( Prof Anne-Lise Børresen-Dale - Oslo University Hospital, Oslo, Norway )
17 Dec 2015

NSABP FB-7: Neoadjuvant therapy with neratinib plus trastuzumab in locally advanced HER2-positive breast cancer

Dr Samuel Jacobs - NSABP Foundation, Pittsburgh, USA
NSABP FB-7: Neoadjuvant therapy with neratinib plus trastuzumab in locally advanced HER2-positive breast cancer ( Dr Samuel Jacobs - NSABP Foundation, Pittsburgh, USA )
17 Dec 2015

HER2 status as predictive marker for aromatase inhibitor versus tamoxifen use in early breast cancer

Dr John Bartlett - Ontario Institute for Cancer Research, Toronto, Canada
HER2 status as predictive marker for aromatase inhibitor versus tamoxifen use in early breast cancer ( Dr John Bartlett -  Ontario Institute for Cancer Research, Toronto, Canada )
17 Dec 2015

Trastuzumab emtansine improves overall survival versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cance

Prof Hans Wildiers - University Hospital of Leuven, Leuven, Belgium
Trastuzumab emtansine improves overall survival versus treatment of physician's choice in patients with previously treated  HER2-positive metastatic breast cance ( Prof Hans Wildiers - University Hospital of Leuven, Leuven, Belgium )
17 Dec 2015